Connect your AI

Fair Isaac FICO Concentration Risk %

Concentration Risk % at other companies

IdentiveINVE

10.3%+7.7pp

Heartland ExpressHTLD

32%+6.0pp

Enovix CorporationENVX

83%+36.0pp

RF IndustriesRFIL

100%0.0pp

Weis MarketsWMK

100%0.0pp

Gyre Therapeutics, Inc.GYRE

93.1%-5.3pp

Segments

By product

Business-to-business Scores88%+7.3%

SaaS software61%+10.9%

Non-platform software56%-18.8%

Platform software44%+41.9%

On-premises software39%-13.3%

Business-to-consumer Scores12%-33.3%

By geography

Americas90%+4.7%

Europe, Middle East and Africa7%-22.2%

Asia Pacific3%-40.0%

By segment

Scores100%0.0%

Other financials

Income statement

Revenue$691.7M+38.7%

Gross profit$600.5M+46.1%

Operating income$402.5M+63.8%

Net income$264.5M+62.6%

EPS (diluted)$11.14+69.0%

Balance sheet

Cash & equivalents$219.4M+54.7%

Total debt$3.7B+42.6%

Total equity-$2.1B-87.0%

Total assets$2.0B+11.6%

Cash flow

Operating cash flow$223.4M+198%

CapEx$266.0K-87.4%

Free cash flow$223.1M+206%

Valuation

Market cap$27.71B-33.3%

Enterprise value$31.15B-29.7%

P/E36.5×-29.2×

P/S12.3×-9.3×

Profitability

Gross margin84.2%+3.3pp

Operating margin50.4%+6.2pp

Net margin33.7%+2.3pp

FCF margin39.9%+1.8pp

Returns & leverage

Return on equity196.4%—

Debt / equity8.9×—

Current ratio2.2×+0.1×